Introduction
Total knee replacement (TKR) is commonly performed to reduce chronic pain and improve the functional state of patients suffering from New knowledge added by this study • Levobupivacaine concentration as low as 0.08% provided adequate analgesia in our patients with minimal muscle weakness and mild numbness.
• Co-ordinated pathways featuring the use of continuous femoral nerve blockade were effective and appreciated by our patients.
Implications for clinical practice or policy
• Work is necessary to identify areas of improvement to shorten hospital stays and hasten recovery without compromising outcomes and wellbeing.
• A multidisciplinary approach to total knee replacement patients can be applied to other surgical groups, for whom suitable studies should be conducted to investigate possible overall benefit.
A B S T R A C T

Objectives:
To evaluate the effectiveness of our new multidisciplinary pathway for total knee replacement patients and compare outcomes after continuous femoral nerve blockade versus conventional patientcontrolled analgesia for postoperative pain.
Design: Randomised controlled trial in a routine clinical setting.
Setting: Acute orthopaedic wards and operating theatres, Yan Chai Hospital, Hong Kong.
Patients: Sixty patients underwent elective unilateral total knee replacement under spinal anaesthesia from May 2009 to September 2011 and were randomly assigned to continuous femoral nerve blockade or conventional patient-controlled analgesia (30 patients in each group).
Main outcome measures:
Quality of pain control was evaluated by pain scores at rest and during mobilisation, opioid consumption, frequency of sideeffects, and patient satisfaction score. Rehabilitation progress was assessed according to the day of first starting weight-bearing exercise, day of independent walking in the ward with aid, Timed Up and Go test, and time elapsing till discharge. Surgical outcome was assessed by the Knee Society score 6 months after discharge, re-admissions, and occurrence of complications.
Results: Patients having continuous femoral nerve
Elective unilateral total knee replacement using continuous femoral nerve blockade versus conventional patient-controlled analgesia: perioperative patient management based on a multidisciplinary pathway carers, 1 for which well-coordinated clinical pathways on postoperative management have been shown to reduce hospital costs and improve quality of life of patients. [2] [3] [4] Postoperative analgesia is an essential part of every pathway. [5] [6] [7] Choices for postoperative analgesia are many. They include conventional patient-controlled analgesia (PCA) and various neuraxial and peripheral nerve blocks. 8, 9 In our new pathway, we featured the use of continuous femoral nerve blockade (CFNB) against our conventional PCA, because CFNB was shown to provide better analgesia, reduce patient opioid consumption and resulting side-effects. 8, 10 Various institutions also reported faster achievement of discharge criteria, 11 quicker mobilisation, 12 and better recovery at 6-week postoperation. 13 The use of CFNB, together with a multimodal analgesic regimen, can provide better postoperative pain relief and hasten the speed of rehabilitation and mobilisation while minimising the drug side-effects. [14] [15] [16] Our new multidisciplinary pathway comprised the following: 
Methods
This was a randomised controlled trial using a structured questionnaire and data retrieval forms, and was conducted in orthopaedic wards and operating theatres (OTs) (3/10) , an alpha of 0.05 (2-sided), and power of 0.8. These 60 patients were randomised to the CFNB and PCA groups (30 patients in each), using computer-generated random numbers. Subjects were divided into two groups (odd against even numbers generated by the computer). The case allocation was concealed in sealed envelopes and the mode of analgesia revealed to case anaesthetist and patient after the patient was included in the study. No blinding was feasible for ward doctors, nurses, and physiotherapists due to practical constraints (different machine types being placed by the bedside). All cases were managed according to our new multidisciplinary TKR pathway (Appendix 2) and multimodal analgesic regimen (Appendix 1). Data were extracted from the preoperative period till 6 months after discharge from hospital. For CFNB patients, the relevant catheter was inserted under nerve stimulation and ultrasound guidance, and before the performance of SA inside the OT a correct position was confirmed by the case anaesthetist with ice and ultrasound in the induction/ recovery room. A standardised bolus of 15 mL 0.5% levobupivacaine was injected after insertion of the CFNB catheter. Successful femoral nerve blockade was ensured by testing with ice before performance of SA. Patients were then started on a continuous infusion of 8 to 12 mL/h of 0.08% levobupivacaine postoperatively in the recovery area till POD 3 (4-day infusion regimen) when the catheter was removed (in the ward by an anaesthetist). Regarding the PCA patients, they were allowed intravenous morphine after the operation, starting in the recovery area.
Both CFNB and PCA groups were started on a standardised multimodal analgesic regimen (if not contra-indicated) that entailed paracetamol, sustained release diclofenate, opioids (codeine or morphine), and drugs to prevent the side-effects from these analgesics (Appendix 2).
Both patient groups received SA using a 25G Quincke spinal needle and local anaesthetics injected intrathecally to achieve a block of at least T10 for the surgery. Then they underwent TKR using a tourniquet which was inflated to pressures of 250 to 280 mm Hg before skin incision. The tourniquet was deflated after bandages were applied at the end of surgery. Cement was used in all cases. A drain was inserted using suction and reviewed by surgeons and ward nurses on POD 1 (during the surgeon's morning round). At that round, decisions were made as to whether the drain could be safely removed, the patient was fit to go for X-ray, and undergo mobilisation in the ward on that day (under supervision of the physiotherapist). Thereafter, the physiotherapist assessed the patient's fitness to step up the intensity of exercise in the ward and then in the gymnasium of the Department of Physiotherapy (without monitoring by a nurse). Until discharge, each patient's pain intensity and complications were monitored closely by ward nurses and surgeons.
Routine ultrasound screening was performed on PODs 4-5 to detect the early occurrence of DVT. All patients had sequential leg compressors applied and started on early mobilisation postoperatively from POD 1 if possible (to prevent DVT).
Data were collected on the quality of pain control (pain scores on visual analogue scale [VAS] of 1-10 at rest and during mobilisation, supervised by physiotherapist), opioid consumption and the frequency of side-effects (by ward nurse and anaesthetist doing pain rounds twice per day), patient satisfaction score (VAS 1-10 on the quality of analgesia by the pain anaesthetist), and discontinuation of PCA or CFNB. The progress of rehabilitation (from the day of mobilisation and independent walking in the ward), the Timed Up and Go test (conducted by the physiotherapist), and surgical outcomes were also recorded. Surgical outcomes entailed Knee Society scores (assessed preoperatively, upon discharge, and then 6 weeks and 6 months after discharge), complications, re-admissions, and mortality (all assessed by orthopaedic surgeons). All data were analysed using the Statistical Package for the Social Sciences (Windows version 10.0; SPSS Inc, Chicago [IL], US), and outcome measures were compared using Student's t tests and Chi squared tests.
Results
In all, 79 patients were recruited but 19 were excluded for various reasons (Box), and replacements were recruited using the permuted block technique. Eventually 30 patients each were recruited as the CFNB and PCA groups. Basic demographic data, intra-operative surgical and anaesthetic parameters in the two groups were similar (Table 1) .
Regarding the quality of pain control, the CFNB patients tended to have lower pain scores during mobilisation on PODs 1 and 2 than those in the PCA group (Table 2) , but their pain scores at rest were similar. For the sake of comparison, opioid consumption of each patient was converted to equivalent dosages of intravenous morphine. On this basis, the CFNB group consumed significantly less opioid than the PCA group only on PODs 0-1 (P<0.05), but more opioid on POD 3 ( Table 2) . Fewer patients suffered from opioid side-effects in the CFNB than PCA group on all PODs (nausea and/or vomiting 27% vs 63%, and dizziness 17% vs 40%; P<0.05 for both; Table 3 ). Mild catheter site oozing and mild limb numbness were reported in about one third of the CFNB patients. Notably, nonsteroidal anti-inflammatory drug (NSAID)-related complications were rare in both groups. Patients were more satisfied with the quality of pain control by CFNB than PCA (Table 4 ; P=0.05). More patients would use the same form of postoperative analgesia again for TKR in the CFNB than PCA group (67% vs 50%, respectively).
Concerning rehabilitation, more CFNB than PCA patients started mobilisation on POD 1 (83% vs 50%, respectively, P=0.012; Table 5 ). The mean day of independent walking in the ward was also earlier (POD 6 vs 8; P=0.047). Significant dizziness, and nausea and vomiting were the main reasons for delayed early mobilisation in the PCA group. We were unable to draw conclusions for the Timed Up and Go test because of missing data (30%). No accidental fall, injury, or complaint was reported throughout the study period.
Regarding surgical outcomes, the mean duration of hospitalisation, in-hospital surgical BOX. Excluded cases and reasons for exclusion complications (bleeding, DVT, sepsis, etc) and Knee Society score and functional score changes from the preoperative period till the 6-month follow-up were similar in both groups (Table 6 ). In all, DVT was detected in five patients (on PODs 4-5): three were in the PCA group (2 had a body mass index [BMI] of >36 kg/m 2 ). There was no other known predisposing factor for DVT in either group, and no pulmonary embolism or mortality was reported. Surgical infection occurred in two patients (1 in each group), for which they underwent re-operation.
As to the efficiency of our new TKR pathway, introduction of CFNB analgesia caused only a minimal effect on case turnover, as such cases were sent to the OT earlier to allow prior performance of the CFNB that was tested in the recovery/ induction area before the previous case ended. The mean waiting time pending transferral to the 
Discussion
For TKR patients, our results showed favourable analgesic outcomes with the use of CFNB as compared to conventional PCA. The former was associated with lower pain scores during mobilisation (not at rest) and reduced opioid consumption and corresponding side-effects, which agreed well with previous studies. 8, 12 A larger sample size or further addition of new analgesics to our current regimen may be necessary to reveal a statistically significant difference in pain scores. Significantly more patients were able to mobilise on POD 1 in the CFNB group, which achieved better patient morale, and a sense of control and satisfaction. Earlier mobilisation was made possible due to better analgesia by CFNB and its opioid-sparing effect caused fewer distressing sideeffects (nausea, vomiting, and dizziness). However, there was possible unintended over-treatment with opioids in the CFNB group from PODs 2-3 (when pain intensity had dropped markedly). Modifications were considered either to reduce the standard opioid dosage or attempt earlier removal of the catheter (on POD 2 instead of 3) so as to facilitate earlier aggressive exercise in the physiotherapy gymnasium. On the contrary, the PCA patients were less satisfied with quality of pain control; most of their distress being due to opioid-related side-effects that hindered activation and interfered with mobilisation on POD 1. There may have been under-utilisation of opioids in both groups, because the patients choose not to activate for further morphine boluses to avoid nausea/vomiting and dizziness despite moderate pain; but the extent of this effect was not estimated. In about two thirds of patients in both groups, NSAIDs were prescribed and transient renal impairment on POD 4 warranted stopping them in a few instances. Routine monitoring of renal function on POD 3 was not indicated, given our limited period of NSAID prescription (4 days) and the low frequency of renal impairment on POD 4.
Rehabilitation appeared to be faster with CFNB. No accidental dislodgement of CFNB/PCA catheters or patient injury was reported during physiotherapy with the machines and catheters in situ. The PCA group started independent walking * Expressed as mg of intravenous morphine equivalent † N/A denotes not applicable as patient attempted first mobilisation on postoperative day 1 ‡ Student's t test in the ward earlier than CFNB group was possibly due to unavailability of services during weekends and public holidays. This manpower limitation may have affected less than 10% of our subjects, and was overcome in the middle of the study, when surgeons allocated more TKRs to be performed earlier in the week to facilitate continued physiotherapy in the immediate postoperative period. Long-term outcomes were similar as reflected by knee score changes. Mobility and function were both improved. Most patients were taking only simple analgesics (eg paracetamol as required) for any residual pain. In both groups, DVT occurred in a minority of cases, with a frequency similar to that usually encountered in our hospital (8-10%). All subjects were encouraged to mobilise early to minimise DVT and foot pumps were applied from POD 0; two patients in PCA group were extremely obese (BMI >36 kg/m 2 ). In such patients, there may be coexisting obstructive sleep apnoea and cardiovascular problems that warrant intensive care unit monitoring. However, beds may not always be available for such elective cases, resulting in unwanted cancellations on the proposed day of surgery. The role of CFNB, SA, and multimodal analgesics appear essential in this situation, so as to facilitate opioid sparing and reduce respiratory depression in the general ward while providing safer and better analgesia than PCA morphine. With better co-ordination, CFNB can be safely used and removed with concomitant use of low-molecular-weight heparin in high-risk cases. After our study, local guidelines have evolved to offer such patients regional blocks together with anticoagulation.
The work logistics with the introduction of CFNB to our TKR patients were efficient and different carers co-ordinated well to minimise disturbance to OT turnover and ensure patient safety and comfort during the whole process of rehabilitation. Despite achieving earlier mobilisation, we were unable to attain hospital stays shorter than 13 to 14 days (our pre-study standard), which was mostly for social reasons including lack of home carers, proper assistance for safe rehabilitation at home, personnel to bring patients back for out-patient follow-up and physiotherapy. Further collaboration with occupational therapists and social workers and preoperative psychosocial preparation for patients and their families in the new pre-admission clinic are essential, with a view 
